| Literature DB >> 30634657 |
Young-Gyun Seo1, Hyunjung Lim2, YoonMyung Kim3, Young-Su Ju4, Hye-Ja Lee5, Han Byul Jang6, Sang Ick Park7, Kyung Hee Park8.
Abstract
This study aimed to develop a multidisciplinary lifestyle intervention program targeted at children and adolescents with moderate to severe obesity, and assess the additional effects of exercise intervention when compared to usual care. Overall, the 103 enrolled participants were ≥85th percentile of age and sex-specific body mass index (BMI). Participants were divided into groups that received 16 weeks of either usual care or exercise intervention. The BMI z-score of the overall completers decreased by about 0.05 after the 16-week intervention (p = 0.02). After the intervention, only the exercise group had a significantly lower BMI z-score than the baseline score by about 0.1 (p = 0.03), but no significant group by time interaction effects were observed. At the 16-week follow-up, significant group by time interaction effects were observed in percentage body fat (%BF) (β = -1.52, 95%CI = -2.58⁻-0.45), lean body mass (LM) (β = 1.20, 95%CI = 0.12⁻2.29), diastolic blood pressure (β = -5.24, 95%CI = -9.66⁻-0.83), high-sensitivity C-reactive protein (β = -1.67, 95%CI = -2.77⁻-1.01), and wall sit test score (β = 50.74, 95%CI = 32.30⁻69.18). We developed a moderate-intensity intervention program that can be sustained in the real-world setting and is practically applicable to both moderate and severe obesity. After interventions, the exercise group had lower %BF and cardiometabolic risk markers, and higher LM and leg muscle strength compared to the usual care group.Entities:
Keywords: adolescents; body composition; cardiometabolic risk; childhood obesity; exercise; intervention; lifestyle; nutrition; pediatrics; severe obesity
Mesh:
Year: 2019 PMID: 30634657 PMCID: PMC6356576 DOI: 10.3390/nu11010137
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Participant flowchart.
Figure 2Intervention flowchart.
The contents of the workbook.
| Visit | Title | Contents |
|---|---|---|
| Screening | Know my body | Baseline tests |
| 1st visit | Learn my body 1 | One-to-one medical consultation/Goal setting. |
| Manage my body 1–1 | Why should I adjust my weight? | |
| Manage my body 1–2 | Let’s take a look at my lifestyle. | |
| Manage my body 1–3 | What makes this process so challenging? | |
| 2nd visit | Learn my body 2 | What changes in my body? |
| Manage my body 2–1 | What is the obstacle to my weight control? | |
| Manage my body 2–2 | What is the lifestyle of our family? | |
| Manage my body 2–3 | My appearance that I think, and my appearance that others think. | |
| 3rd visit | Learn my body 3 | What changes in my body? |
| Manage my body 3–1 | Eating only a small amount cannot control my weight. | |
| Manage my body 3–2 | Keep my daily life healthy. | |
| Manage my body 3–3 | Be confident. | |
| 4th visit | Learn my body 4 | What changes in my body? |
| Manage my body 4–1 | What makes this process so challenging? | |
| Manage my body 4–2 | How much have I changed? | |
| Manage my body 4–3 | Weight control is not done at once. | |
| 5th visit | Keep my body | 2nd tests/One-to-one medical consultation. |
Monthly key messages and action plan for nutritional counseling.
| Session | Contents |
|---|---|
| 1 | My meal planning |
| 2 | My meal portion |
| 3 | Choose healthy snack |
| 4 | Cook with fruits and vegetables |
| 5 | Maintain my healthy diet |
Weekly schedule and protocol for Intervention for Childhood and Adolescents Obesity via Activity and Nutrition (ICAAN) Exercise.
| Week | ICAAN Exercise Protocol |
|---|---|
| 1/7 | Butt Kicker → Diagonal Chop → Plank Jack → Skater Jump → Squat → Plank |
| 2/8 | Halo Slam → Power Skip → Rotational Chop → Running Mountain Climber → Lunge → Plank |
| 3/9 | Alternating Fast Feet → In and Out Squat → Side to Side Mountain Climber → Skier Swing → Wall Sit → Plank |
| 4/10 | Jumping Jack → Long Jump to Backward Hop → Punch → Slam → Wall Squat → Plank |
| 5/11 | High Knee Run → Mountain Climber → Speed Walkout → Box Squat Jump → Buffy → Plank |
| 6/12 | Squat → Lunge → Side to Side Mountain Climber → Jumping Jack → Buffy → Plank |
Baseline demographic characteristics, anthropometric measurements, laboratory test results, lifestyle measurements, and fitness test results of all participants and completers.
| Characteristic | All Participants | Completers | ||||
|---|---|---|---|---|---|---|
| Usual Care Group ( | Exercise Group ( | Usual Care Group ( | Exercise Group ( | |||
|
| 12.39 ± 2.07 | 12.92 ± 1.69 | 0.21 | 12.09 ± 2.20 | 12.80 ± 1.72 | 0.16 |
|
| 0.85 | 0.88 | ||||
| Male | 43 (60.56) | 20 (62.50) | 28 (63.64) | 17 (65.38) | ||
| Female | 28 (39.44) | 12 (37.50) | 16 (36.36) | 9 (34.62) | ||
|
| 0.62 | 0.73 | ||||
| None | 14 (24.14) | 5 (19.23) | 7 (18.92) | 3 (13.64) | ||
| Either | 44 (75.86) | 21 (80.77) | 30 (81.08) | 19 (86.36) | ||
|
| 0.37 | 0.51 | ||||
| None | 29 (52.73) | 10 (41.67) | 18 (51.43) | 8 (42.11) | ||
| Either | 26 (47.27) | 14 (58.33) | 17 (48.57) | 11 (57.89) | ||
|
| 0.63 | 0.81 | ||||
| <College (both) | 18 (31.03) | 7 (25.93) | 11 (28.95) | 6 (26.09) | ||
| ≥College (either) | 40 (68.97) | 20 (74.07) | 27 (71.05) | 17 (73.91) | ||
|
| 0.93 | 0.75 | ||||
| <3 million KRW | 8 (14.04) | 4 (15.38) | 5 (13.89) | 2 (9.52) | ||
| 3–5 million KRW | 20 (35.09) | 8 (30.77) | 14 (38.89) | 7 (33.33) | ||
| ≥5 million KRW | 29 (50.88) | 14 (53.85) | 17 (47.22) | 12 (57.14) | ||
|
| 0.17 | 0.35 | ||||
| Living together with parents | 55 (91.67) | 22 (81.48) | 37 (94.87) | 20 (86.96) | ||
| Other situation | 5 (8.33) | 5 (18.52) | 2 (5.13) | 3 (13.04) | ||
|
| 3.32 ± 0.43 | 3.33 ± 0.61 | 0.96 | 3.39 ± 0.46 | 3.34 ± 0.64 | 0.76 |
|
| 73.17 ± 17.91 | 78.05 ± 13.38 | 0.17 | 72.16 ± 19.88 | 77.43 ± 11.34 | 0.22 |
|
| 29.56 ± 4.23 | 30.33 ± 4.06 | 0.39 | 29.43 ± 4.81 | 30.06 ± 3.40 | 0.56 |
|
| 2.32 ± 0.45 | 2.34 ± 0.54 | 0.87 | 2.32 ± 0.48 | 2.32 ± 0.52 | 0.98 |
|
| 115.95 ± 1.11 | 116.63 ± 1.14 | 0.81 | 116.22 ± 1.13 | 116.02 ± 1.12 | 0.95 |
|
| 93.50 ± 11.38 | 97.50 ± 9.58 | 0.09 | 93.43 ± 11.79 | 97.61 ± 8.59 | 0.12 |
|
| 30.38 ± 8.17 | 32.48 ± 7.65 | 0.22 | 29.75 ± 9.40 | 32.33 ± 6.38 | 0.22 |
|
| 41.64 ± 3.77 | 41.53 ± 4.42 | 0.90 | 41.26 ± 4.25 | 41.77 ± 4.23 | 0.63 |
|
| 40.57 ± 10.17 | 43.28 ± 6.89 | 0.17 | 40.18 ± 10.98 | 42.85 ± 6.41 | 0.26 |
|
| 124.33 ± 14.71 | 126.27 ± 14.85 | 0.54 | 123.24 ± 15.69 | 125.92 ± 14.99 | 0.49 |
|
| 66.87 ± 7.38 | 65.70 ± 6.72 | 0.45 | 66.67 ± 7.64 | 65.60 ± 6.72 | 0.55 |
|
| ||||||
| HOMA-IR * | 4.33 ± 1.73 | 4.99 ± 2.01 | 0.27 | 4.17 ± 1.84 | 5.28 ± 2.09 | 0.15 |
| HDL-C, mg/dL | 46.44 ± 8.98 | 47.38 ± 10.60 | 0.64 | 47.45 ± 9.51 | 49.54 ± 10.42 | 0.40 |
| LDL-C, mg/dL | 114.24 ± 24.74 | 111.78 ± 26.35 | 0.65 | 113.59 ± 22.62 | 110.15 ± 28.04 | 0.58 |
| TG, mg/dL * | 102.82 ± 1.50 | 111.32 ± 1.63 | 0.39 | 98.27 ± 1.50 | 108.92 ± 1.63 | 0.34 |
| AST, U/L * | 22.76 ± 1.53 | 25.74 ± 1.86 | 0.24 | 23.30 ± 1.53 | 26.23 ± 1.90 | 0.36 |
| ALT, U/L * | 24.68 ± 2.13 | 29.90 ± 2.55 | 0.27 | 25.30 ± 2.22 | 31.56 ± 2.61 | 0.30 |
| GGT, U/L * | 20.42 ± 1.70 | 23.26 ± 1.87 | 0.28 | 20.23 ± 1.78 | 23.34 ± 1.96 | 0.35 |
| CRP, mg/L * | 1.49 ± 2.79 | 1.73 ± 2.64 | 0.50 | 1.44 ± 3.01 | 1.87 ± 2.76 | 0.32 |
|
| ||||||
| Total energy intake, kcal | 2362.5 ± 578.7 | 2548.0 ± 551.3 | 0.13 | 2368.6 ± 429.3 | 2509.8 ± 559.9 | 0.24 |
|
| ||||||
| Sleep time, hour | 8.38 ± 1.21 | 8.54 ± 1.54 | 0.60 | 8.47 ± 1.22 | 8.47 ± 1.43 | 0.99 |
| Inactivity time, hour | 2.76 ± 1.78 | 3.79 ± 3.19 | 0.05 | 2.77 ± 1.80 | 3.62 ± 2.89 | 0.15 |
|
| ||||||
| Step test, post exam HR | 127.51 ± 21.85 | 128.46 ± 20.88 | 0.85 | 127.42 ± 22.14 | 123.95 ± 19.41 | 0.54 |
| Arm curl test, frequency | 16.03 ± 6.36 | 17.00 ± 5.66 | 0.49 | 15.92 ± 7.13 | 16.86 ± 5.64 | 0.60 |
| Wall sit test, sec | 43.11 ± 26.68 | 36.58 ± 23.70 | 0.27 | 47.11 ± 28.91 | 36.27 ± 23.19 | 0.14 |
Abbreviations: CVD, cardiovascular disease; KRW, Korean Republic Won; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HOMA-IR, homeostasis model assessment for insulin resistance; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglyceride; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, gamma-glutamyl transferase; CRP, high-sensitivity C-reactive protein; HR, heart rate. HOMA-IR = (fasting plasma glucose level (in milligrams per deciliter) × fasting plasma insulin level (in microunits per milliliter))/405. Data are presented as mean ± standard deviation for continuous variables (t test) and number (%) for categorical variables (χ2 test or Fisher’s exact test). Percentages have been rounded and may not total 100. * Geometric mean ± standard deviation. a Completers.
Changes in primary outcomes of usual care and exercise groups.
| Outcome Measure | Usual Care Group ( | Exercise Group ( | β (95%CI) b | β (95%CI) c |
|---|---|---|---|---|
|
| ||||
| Baseline | 2.32 ± 0.48 | 2.32 ± 0.52 | ||
| 16-wk follow-up | 2.29 ± 0.53 | 2.24 ± 0.56 | −0.04 (−0.12 to 0.03) | −0.02 (−0.13 to 0.10) |
| | 0.19 | 0.03 | ||
|
| ||||
| Baseline | 116.22 ± 1.13 | 116.02 ± 1.12 | ||
| 16-wk follow-up | 115.37 ± 1.14 | 114.10 ± 1.13 | −1.01 (−1.03 to1.01) | −1.00 (−1.03 to 1.02) |
| | 0.16 | 0.04 | ||
Abbreviations: CI, confidence interval; BMI, body mass index; wk, week. Data were expressed as mean ± standard deviation unless otherwise indicated. * Geometric mean ± standard deviation; a paired t-test between baseline data and 16-wk follow-up data. b group × time interaction effects adjusted for age and sex in the mixed effects linear regression models (random intercept: individual). c group × time interaction effects adjusted for age, sex, parental obesity, parental education, monthly household income, marital status, and sleep time, in the mixed effects linear regression models (random intercept: individual).
Changes in secondary outcomes of usual care and exercise groups.
| Outcome Measure | Usual care Group ( | Exercise Group ( | β (95%CI) b | β (95%CI) c |
|---|---|---|---|---|
|
| ||||
|
| ||||
| Baseline | 93.43 ± 11.79 | 97.61 ± 8.59 | ||
| 16-wk follow-up | 93.67 ± 13.97 | 96.32 ± 9.68 | −1.45 (−4.03 to 1.12) | −0.91 (−4.11 to 2.28) |
| | 0.76 | 0.27 | ||
|
| ||||
| Baseline | 29.75 ± 9.40 | 32.33 ± 6.38 | ||
| 16-wk follow-up | 30.42 ± 9.90 | 31.64 ± 6.69 | −1.25 (−2.22 to −0.28) | −1.12 (−2.58 to 0.34) |
| | 0.01 | 0.17 | ||
|
| ||||
| Baseline | 41.26 ± 4.25 | 41.77 ± 4.23 | ||
| 16-wk follow-up | 41.05 ± 4.49 | 40.22 ± 4.62 | −1.31 (−2.07 to −0.54) | −1.52 (−2.58 to −0.45) |
| | 0.37 | <0.001 | ||
|
| ||||
| Baseline | 40.18 ± 10.98 | 42.85 ± 6.41 | ||
| 16-wk follow-up | 41.26 ± 10.96 | 44.55 ± 6.04 | 0.76 (0.02 to 1.50) | 1.20 (0.12 to 2.29) |
| | <0.001 | <0.001 | ||
|
| ||||
|
| ||||
| Baseline | 123.24 ± 15.69 | 125.92 ± 14.99 | ||
| 16-wk follow-up | 123.91 ± 15.95 | 123.06 ± 11.07 | −3.31 (−8.75 to 2.13) | −5.78 (−13.21 to 1.64) |
| | 0.71 | 0.20 | ||
|
| ||||
| Baseline | 66.67 ± 7.64 | 65.60 ± 6.72 | ||
| 16-wk follow-up | 65.59 ± 6.43 | 61.44 ± 9.47 | −3.09 (−6.50 to 0.31) | −5.24 (−9.66 to −0.83) |
| | 0.27 | 0.02 | ||
|
| ||||
| Baseline | 4.17 ± 1.84 | 5.28 ± 2.09 | ||
| 16-wk follow-up | 4.43 ± 1.77 | 4.79 ± 1.80 | −1.14 (−1.39 to 1.07) | −1.20 (−1.47 to 1.02) |
| | 0.36 | 0.24 | ||
|
| ||||
| Baseline | 47.45 ± 9.51 | 49.54 ± 10.42 | ||
| 16-wk follow-up | 47.18 ± 9.97 | 48.42 ± 9.28 | −0.50 (−3.69 to 2.69) | 0.93 (−2.90 to 4.75) |
| | 0.81 | 0.30 | ||
|
| ||||
| Baseline | 113.59 ± 22.62 | 110.15 ± 28.04 | ||
| 16-wk follow-up | 112.23 ± 22.44 | 103.88 ± 24.61 | −5.12 (−12.68 to 2.43) | −4.12 (−14.96 to 6.73) |
| | 0.55 | 0.08 | ||
|
| ||||
| Baseline | 98.27 ± 1.50 | 108.92 ± 1.63 | ||
| 16-wk follow-up | 97.83 ± 1.60 | 103.59 ± 1.60 | −1.04 (−1.27 to 1.18) | −1.17 (−1.47 to 1.07) |
| | 0.94 | 0.59 | ||
|
| ||||
| Baseline | 23.30 ± 1.53 | 26.23 ± 1.90 | ||
| 16-wk follow-up | 22.07 ± 1.56 | 23.73 ± 1.69 | −1.05 (−1.17 to 1.07) | 1.04 (−1.11 to 1.20) |
| | 0.13 | 0.06 | ||
|
| ||||
| Baseline | 25.30 ± 2.22 | 31.56 ± 2.61 | ||
| 16-wk follow-up | 23.05 ± 2.23 | 26.49 ± 2.35 | −1.08 (−1.28 to 1.10) | 1.01 (−1.22 to 1.25) |
| | 0.14 | 0.002 | ||
|
| ||||
| Baseline | 20.23 ± 1.78 | 23.34 ± 1.96 | ||
| 16-wk follow-up | 21.03 ± 1.78 | 20.99 ± 1.84 | −1.15 (−1.27 to −1.04) | −1.08 (−1.24 to 1.05) |
| | 0.27 | 0.01 | ||
|
| ||||
| Baseline | 1.44 ± 3.01 | 1.87 ± 2.76 | ||
| 16-wk follow-up | 1.53 ± 2.92 | 1.19 ± 2.46 | −1.61 (−2.33 to −1.11) | −1.67 (−2.77 to −1.01) |
| | 0.60 | 0.02 | ||
|
| ||||
|
| ||||
| Baseline | 2367.2 ± 424.9 | 2509.8 ± 559.9 | ||
| 16-wk follow-up | 2022.5 ± 521.6 | 1965.4 ± 409.0 | −244.8 (−565.5 to 75.8) | −44.9 (−429.9 to 340.0) |
| | 0.001 | <0.001 | ||
|
| ||||
|
| ||||
| Baseline | 128.22 ± 22.49 | 123.95 ± 19.41 | ||
| 16 wk follow-up | 122.94 ± 18.67 | 120.18 ± 23.64 | −7.07 (−20.95 to 6.81) | −9.52 (−26.07 to 7.03) |
| | 0.30 | 0.53 | ||
|
| ||||
| Baseline | 16.17 ± 7.20 | 16.86 ± 5.64 | ||
| 16-wk follow-up | 17.22 ± 4.32 | 19.36 ± 4.84 | 1.00 (−1.67 to 3.67) | 1.47 (−2.36 to 5.29) |
| | 0.33 | 0.02 | ||
|
| ||||
| Baseline | 46.12 ± 29.11 | 36.27 ± 23.19 | ||
| 16-wk follow-up | 54.92 ± 32.65 | 78.47 ± 40.88 | 34.26 (19.65 to 48.88) | 50.74 (32.30 to 69.18) |
| | 0.07 | <0.001 | ||
Abbreviations: CI, confidence interval; wk, week; SBP, systolic blood pressure; DBP, diastolic blood pressure; HOMA-IR, homeostasis model assessment for insulin resistance; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglyceride; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, gamma-glutamyl transferase; CRP, high-sensitivity C-reactive protein; HR, heart rate. HOMA-IR = (fasting plasma glucose level (in milligrams per deciliter) × fasting plasma insulin level (in microunits per milliliter))/405. Data are expressed as mean ± standard deviation unless otherwise indicated. * Geometric mean ± standard deviation; a paired t-test between baseline data and 16-wk follow-up data. b group × time interaction effects adjusted for age and sex in the mixed effects linear regression models (random intercept: individual). c group × time interaction effects adjusted for age, sex, parental obesity, parental education, monthly household income, marital status, and sleep time in the mixed effects linear regression models (random intercept: individual).